ロード中...
Inhibition of P-Selectin and PSGL-1 Using Humanized Monoclonal Antibodies Increases the Sensitivity of Multiple Myeloma Cells to Bortezomib
Multiple myeloma (MM) is a plasma cell malignancy localized in the bone marrow. Despite the introduction of novel therapies majority of MM patients relapse. We have previously shown that inhibition of P-selectin and P-selectin glycoprotein ligand-1 (PSGL-1) play a key role in proliferation of MM and...
保存先:
| 出版年: | Biomed Res Int |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi Publishing Corporation
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4619821/ https://ncbi.nlm.nih.gov/pubmed/26539491 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/417586 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|